Skip to main content
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Centene Corporation Common Stock (NY:CNC)

35.76 -2.07 (-5.47%)
Official Closing Price Updated: 7:00 PM EDT, Oct 10, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Centene Corporation Common Stock

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
28 29 Next >
This PayPal Analyst Turns Bullish; Here Are Top 5 Upgrades For Friday
 
Via Benzinga
C-Suite Buy of the Week: Executives' Investments Offer Clues to Market Directions
 
Via Benzinga
Why Is Insurance Firm Centene Stock Trading Higher On Thursday?
Centene reveals 2025 guidance, expecting revenues up to $169.5 bilion and adjusted EPS over $7.25. HBR and SG&A ratios align with strategic targets. 
Via Benzinga
$1000 Invested In Centene 20 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Centene Stock: A Deep Dive Into Analyst Perspectives (8 Ratings)
 
Via Benzinga
UnitedHealth Stock Rises; Analyst Backs UnitedHealthcare Parent After CEO's Murder
UnitedHealth stock recovered some lost ground as Wall Street assesses whether the killing of the UnitedHealthcare insurance division CEO will hurt profitability. 
Via Investor's Business Daily
Looking Into Centene's Recent Short Interest
 
Via Benzinga
(CNC) - Analyzing Centene's Short Interest
 
Via Benzinga
Centene Options Trading: A Deep Dive into Market Sentiment
 
Via Benzinga
Stock Market Hits Highs On Salesforce, Tech Earnings; Bitcoin Tops $100,000, Briefly: Weekly Review
Salesforce and mostly positive tech earnings buoyed the major indexes. 
Via Investor's Business Daily
UnitedHealth Rises On Medicare Star Ratings Ruling; Humana Rallies
A federal judge ordered a rerating of the its Medicare Advantage star ratings. Humana also rallied. 
Via Investor's Business Daily
3 Stocks Seeing Insider Buys: CNC, PFE, BMY
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. Let’s take a closer look at the transactions for those interested in trading like the insiders. 
Via Talk Markets
Donald Trump's Second Term Could Reshape US Healthcare System, With Major Impacts on Affordable Care Act And Medicare
Trump's second term could bring significant changes to U.S. healthcare, with cuts to ACA subsidies and potential Medicare privatization. 
Via Benzinga
Topics Government
Key Takeaways From Centene Analyst Ratings
 
Via Benzinga
Medicare Advantage Costs Surge: How These 2 Insurers Are Thriving
Health insurers face rising costs in Medicare Advantage. Centene and Molina stay profitable by focusing on Medicaid despite high Medical Benefits Ratios. 
Via MarketBeat
S&P 500, Nasdaq Rise Sharply Ending 3-Day Losing Streak; Viking Therapeutics Surge, While Capri’s Shares Slump
US benchmark equity averages rose on Friday as the market ended a three-day losing streak. 
Via Talk Markets
Topics Stocks
Centene (CNC) Q3 2024 Earnings Call Transcript
CNC earnings call for the period ending September 30, 2024. 
Via The Motley Fool
Topics Earnings
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Earnings Outlook For Centene
 
Via Benzinga
$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Looking Into Centene's Recent Short Interest
 
Via Benzinga
Tech Stocks Rally As Investors Await Magnificent 7 Earnings; Dollar Eyes Fourth Straight Positive Week: What's Driving Markets Friday?
Stocks are ending the week on a high note, with tech leading the charge as investors position ahead of next week’s pivotal earnings releases from five of the “Magnificent Seven” stocks. 
Via Benzinga
Centene Says It Is Positioned To Capture Long-Term Growth In Government-Sponsored Healthcare, Lifts Annual Outlook
Centene reported Q3 sales of $42.02 billion, surpassing expectations. Adjusted EPS reached $1.62, driven by Medicaid rate increases and membership growth. 
Via Benzinga
Cigna-Humana Merger Talks Back On With Tables Turned; 2024 Election Is Key
Cigna-Humana merger talks are back on, nearly one year after the first try. The price may be more affordable after CI stock outperformed, while HUM struggled. 
Via Investor's Business Daily
Here's How Much $100 Invested In Centene 20 Years Ago Would Be Worth Today
 
Via Benzinga
Looking Into Centene's Recent Short Interest
 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $1,600 Today
 
Via Benzinga
NIO, ASML, And CVS Health Are Among Top 10 Large Cap Losers Last Week (Oct 14-18): Are The Others In Your Portfolio?
10 worst performing stocks last week: NIO -16.35%, KLAC -15.58%, CNC -14.38%, Elevance -14.17%, ASML -13.97%, PDD -13.91%, MOH -12.24%, LRCX -12.12%, ERIE -9.92%, CVS -9.44% 
Via Benzinga
UnitedHealth Beats But Reins In Outlook As Costs Rise; UNH Stock Slips
The Dow giant's Optum services unit generated over 50% of operating income. 
Via Investor's Business Daily
Topics Stocks
Centene Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)
 
Via Benzinga
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.